ETNB 89bio | $8.63 -3.8% | 5/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 5/17/2024 |
AMAT Applied Materials | $212.08 -0.9% | 5/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 5/17/2024 |
DESP Despegar.com | $14.94 +19.1% | 5/17/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 5/17/2024 |
ABBV AbbVie | $166.42 +1.3% | 5/17/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | $200.00 | Low | View details for Cantor Fitzgerald rating of AbbVie (NYSE:ABBV) on 5/17/2024 |
PGNY Progyny | $28.09 +2.0% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $48.00 | Low | View details for Cantor Fitzgerald rating of Progyny (NASDAQ:PGNY) on 5/16/2024 |
MREO Mereo BioPharma Group | $3.20 -2.1% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 5/16/2024 |
|
VNRX VolitionRx | $0.77 -3.8% | 5/16/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 5/16/2024 |
ABEO Abeona Therapeutics | $4.40 -4.3% | 5/16/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 5/16/2024 |
BLTE Belite Bio | $44.97 +6.1% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Belite Bio (NASDAQ:BLTE) on 5/15/2024 |
LUCD Lucid Diagnostics | $0.91 +2.3% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 5/15/2024 |
ASND Ascendis Pharma A/S | $121.12 -1.4% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/15/2024 |
SMTI Sanara MedTech | $30.51 -3.8% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 5/15/2024 |
PGEN Precigen | $1.38 -1.4% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Precigen (NASDAQ:PGEN) on 5/15/2024 |
SSTI SoundThinking | $14.35 +0.5% | 5/15/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 -> $20.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 5/15/2024 |
TSHA Taysha Gene Therapies | $3.09 -1.6% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 5/15/2024 |
IRON Disc Medicine | $32.18 +0.8% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 5/15/2024 |
LUNR Intuitive Machines | $5.14 -3.2% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 5/15/2024 |
CRIS Curis | $11.80 -6.3% | 5/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Curis (NASDAQ:CRIS) on 5/15/2024 |
ADI Analog Devices | $214.08 0.0% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $205.00 -> $240.00 | Low | View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 5/15/2024 |
NXPI NXP Semiconductors | $267.72 -0.7% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $290.00 -> $325.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 5/15/2024 |
TXN Texas Instruments | $195.02 +0.0% | 5/15/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 -> $210.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 5/15/2024 |
HL Hecla Mining | $6.10 +11.1% | 5/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst M. Kozak | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Hecla Mining (NYSE:HL) on 5/9/2024 |
XGN Exagen | $1.88 -0.5% | 5/14/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 -> $7.00 | Low | View details for Cantor Fitzgerald rating of Exagen (NASDAQ:XGN) on 5/14/2024 |
DDD 3D Systems | $3.67 -2.4% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $8.25 | Low | View details for Cantor Fitzgerald rating of 3D Systems (NYSE:DDD) on 5/14/2024 |
CAPR Capricor Therapeutics | $6.20 +9.9% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | Low | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 5/14/2024 |
ATOS Atossa Therapeutics | $1.57 -2.5% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Atossa Therapeutics (NASDAQ:ATOS) on 5/14/2024 |
RCEL AVITA Medical | $8.27 +4.4% | 5/14/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $22.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 5/14/2024 |
CRNX Crinetics Pharmaceuticals | $51.40 -1.0% | 5/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 5/14/2024 |
ADMA ADMA Biologics | $9.21 +1.7% | 5/10/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 5/10/2024 |
ELUT Elutia | $3.31 +2.8% | 5/10/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 5/10/2024 |
RDW Redwire | $4.86 -0.2% | 5/10/2024 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $5.00 -> $6.00 | Low | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 5/10/2024 |
PDSB PDS Biotechnology | $3.49 -1.1% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of PDS Biotechnology (NASDAQ:PDSB) on 5/9/2024 |
PCVX Vaxcyte | $74.57 -1.2% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 5/9/2024 |
PWSC PowerSchool | $19.71 +3.6% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of PowerSchool (NYSE:PWSC) on 5/9/2024 |
INVZ Innoviz Technologies | $1.22 +5.2% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Innoviz Technologies (NASDAQ:INVZ) on 5/9/2024 |
JANX Janux Therapeutics | $47.10 -0.9% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 5/9/2024 |
MIRM Mirum Pharmaceuticals | $24.07 -2.7% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $40.00 | Low | View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/9/2024 |
ALEC Alector | $5.44 -0.9% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Alector (NASDAQ:ALEC) on 5/9/2024 |
MKFG Markforged | $0.46 -2.1% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $1.45 -> $1.30 | Low | View details for Cantor Fitzgerald rating of Markforged (NYSE:MKFG) on 5/9/2024 |
KVYO Klaviyo | $25.36 +4.0% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 5/9/2024 |
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad) For over four decades, Louis Navellier has found the very best tech stocks...
Before the rest of the market. Click for his six specific AI stock in the crosshairs |
MNKD MannKind | $4.59
| 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 5/9/2024 |
LFMD LifeMD | $7.77 +0.6% | 5/9/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $15.00 | Low | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 5/9/2024 |
CRSP CRISPR Therapeutics | $56.22 +1.0% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of CRISPR Therapeutics (NASDAQ:CRSP) on 5/9/2024 |
DCGO DocGo | $3.08 -3.8% | 5/9/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of DocGo (NASDAQ:DCGO) on 5/9/2024 |
NPCE NeuroPace | $8.17 -4.6% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 5/9/2024 |
ACAD ACADIA Pharmaceuticals | $14.79 -0.4% | 5/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/9/2024 |
CATX Perspective Therapeutics | 1.60 +4.6% | 5/9/2024 | Initiated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | N/A | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 5/9/2024 |
EVGO EVgo | $2.28 -3.4% | 5/9/2024 | Upgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Neutral -> Overweight | $5.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 5/9/2024 |
RIVN Rivian Automotive | $10.50 +3.7% | 5/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 -> $15.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 5/8/2024 |
SHLS Shoals Technologies Group | $6.41 -6.3% | 5/8/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 5/8/2024 |
JNJ Johnson & Johnson | $154.64 +0.2% | 5/6/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 5/6/2024 |
GPCR Structure Therapeutics | $36.15 +0.8% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 5/3/2024 |
CYBR CyberArk Software | $246.33 +0.7% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 5/3/2024 |
REGN Regeneron Pharmaceuticals | $982.29 +1.5% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 5/3/2024 |
UDMY Udemy | $9.94 +0.5% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of Udemy (NASDAQ:UDMY) on 5/3/2024 |
LBPH Longboard Pharmaceuticals | $20.69 +0.9% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 5/3/2024 |
ASND Ascendis Pharma A/S | $121.12 -1.4% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 5/3/2024 |
NET Cloudflare | $75.23 +0.1% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 5/3/2024 |
FTNT Fortinet | $61.43 +0.3% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 5/3/2024 |
CI The Cigna Group | $338.71 -0.2% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 5/3/2024 |
RARE Ultragenyx Pharmaceutical | $41.87 -1.7% | 5/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 5/3/2024 |
CERS Cerus | $1.97 +0.5% | 5/3/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 -> $4.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 5/3/2024 |
SPT Sprout Social | $29.93 +0.5% | 5/3/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $74.00 -> $46.00 | Low | View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
CGON CG Oncology | $29.98 -3.2% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $75.00 | Low | View details for Cantor Fitzgerald rating of CG Oncology (NASDAQ:CGON) on 5/2/2024 |
FRSH Freshworks | $13.64 -1.4% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $25.00 -> $19.00 | Low | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 5/2/2024 |
CSGS CSG Systems International | $42.78 -1.0% | 5/2/2024 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $63.00 -> $62.00 | Low | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 5/2/2024 |
QCOM QUALCOMM | $193.86 +0.3% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 5/2/2024 |
SRPT Sarepta Therapeutics | $131.38 -1.0% | 5/2/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $128.00 | Low | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 5/2/2024 |
TSLA Tesla | $177.46 +1.5% | 5/2/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $230.00 | Low | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 5/2/2024 |
CVS CVS Health | $57.68 +0.3% | 5/1/2024 | Downgraded by | Cantor Fitzgerald | Analyst S. James | Overweight -> Neutral | $87.00 -> $58.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 5/1/2024 |
AMD Advanced Micro Devices | $164.47 +1.1% | 5/1/2024 | Target Lowered by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $190.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 5/1/2024 |
FUBO fuboTV | $1.32 -0.8% | 5/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.90 | Low | View details for Cantor Fitzgerald rating of fuboTV (NYSE:FUBO) on 5/1/2024 |
LLY Eli Lilly and Company | $770.00 -0.1% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 -> $885.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/30/2024 |
NXPI NXP Semiconductors | $267.72 -0.7% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/30/2024 |
ATNM Actinium Pharmaceuticals | $9.80 -0.5% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/30/2024 |
CMPS COMPASS Pathways | $7.84 -1.9% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/30/2024 |
COUR Coursera | $8.49 -2.5% | 4/30/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/30/2024 |
ACAD ACADIA Pharmaceuticals | $14.79 -0.4% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/30/2024 |
TSHA Taysha Gene Therapies | $3.09 -1.6% | 4/30/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/30/2024 |
CMCL Caledonia Mining | $11.09 +3.9% | 4/29/2024 | Upgraded by | Cantor Fitzgerald | - | Hold -> Speculative Buy | $13.50 | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 4/29/2024 |
BMRN BioMarin Pharmaceutical | $77.56 +0.8% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $110.00 | Low | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 4/25/2024 |
HUM Humana | $356.20 +0.3% | 4/25/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 -> $360.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/25/2024 |
ENVX Enovix | $10.04 +9.2% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $30.00 | Low | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 4/25/2024 |
LRCX Lam Research | $912.07 -3.3% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/25/2024 |
TER Teradyne | $131.91 +0.3% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 4/25/2024 |
AMED Amedisys | $94.43 -0.5% | 4/25/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $101.00 | Low | View details for Cantor Fitzgerald rating of Amedisys (NASDAQ:AMED) on 4/25/2024 |
TXN Texas Instruments | $195.02 +0.0% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2024 |
ITCI Intra-Cellular Therapies | $65.00 -2.3% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $120.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/24/2024 |
ANNX Annexon | $4.33 -0.7% | 4/24/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/24/2024 |
STX Seagate Technology | $95.27 -3.0% | 4/24/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $95.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 4/24/2024 |
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad) For over four decades, Louis Navellier has found the very best tech stocks...
Before the rest of the market. Click for his six specific AI stock in the crosshairs |
MTLS Materialise | $5.36 +2.9% | 4/24/2024 | Initiated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight | $9.50 | Low | View details for Cantor Fitzgerald rating of Materialise (NASDAQ:MTLS) on 4/24/2024 |
ABEO Abeona Therapeutics | $4.40 -4.3% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $36.00 | N/A | View details for Cantor Fitzgerald rating of Abeona Therapeutics (NASDAQ:ABEO) on 4/23/2024 |
CDTX Cidara Therapeutics | $11.21 -6.6% | 4/23/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/23/2024 |
INCY Incyte | $57.10 +0.4% | 4/23/2024 | Initiated by | Cantor Fitzgerald | - | Neutral | | Low | View details for Cantor Fitzgerald rating of Incyte (NASDAQ:INCY) on 4/23/2024 |
TSHA Taysha Gene Therapies | $3.09 -1.6% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/18/2024 |
ASND Ascendis Pharma A/S | $121.12 -1.4% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/18/2024 |
BHVN Biohaven | $37.37 -2.8% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/18/2024 |
GPCR Structure Therapeutics | $36.15 +0.8% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/18/2024 |
MRK Merck & Co., Inc. | $131.19 +0.2% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/18/2024 |
NVO Novo Nordisk A/S | $131.89 -0.9% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/18/2024 |
CMPS COMPASS Pathways | $7.84 -1.9% | 4/18/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 4/18/2024 |
COUR Coursera | $8.49 -2.5% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $26.00 | Low | View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 4/17/2024 |
CRWD CrowdStrike | $345.93 +2.0% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 4/17/2024 |
CYBR CyberArk Software | $246.33 +0.7% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $300.00 | N/A | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/17/2024 |
DDOG Datadog | $120.07 -0.4% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $150.00 | N/A | View details for Cantor Fitzgerald rating of Datadog (NASDAQ:DDOG) on 4/17/2024 |
FTNT Fortinet | $61.43 +0.3% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $65.00 | N/A | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/17/2024 |
NET Cloudflare | $75.23 +0.1% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $100.00 | N/A | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 4/17/2024 |
PANW Palo Alto Networks | $317.85 +0.3% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $350.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 4/17/2024 |
ZS Zscaler | $178.86 -0.3% | 4/17/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | N/A | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/17/2024 |
KVYO Klaviyo | $25.36 +4.0% | 4/16/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $31.00 | Low | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 4/16/2024 |
REGN Regeneron Pharmaceuticals | $982.29 +1.5% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $925.00 | Low | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/15/2024 |
LLY Eli Lilly and Company | $770.00 -0.1% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/15/2024 |
JNJ Johnson & Johnson | $154.64 +0.2% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 4/15/2024 |
PFE Pfizer | $28.64 -1.0% | 4/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/15/2024 |
ALXO ALX Oncology | $14.21 -3.1% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of ALX Oncology (NASDAQ:ALXO) on 4/12/2024 |
PSNY Polestar Automotive Holding UK | $1.24 -3.1% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 4/12/2024 |
MRVL Marvell Technology | $71.92 -1.6% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $85.00 | Low | View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 4/12/2024 |
HRMY Harmony Biosciences | $29.03 -1.0% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | Low | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 4/12/2024 |
PTCT PTC Therapeutics | $33.10 -2.8% | 4/12/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 4/12/2024 |
SOUN SoundHound AI | $5.05 -1.2% | 4/11/2024 | Upgraded by | Cantor Fitzgerald | - | Underweight -> Neutral | $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 4/11/2024 |
PRTA Prothena | $22.52 -3.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 4/10/2024 |
BHVN Biohaven | $37.37 -2.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Biohaven (NYSE:BHVN) on 4/10/2024 |
RCM R1 RCM | $12.43 +1.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 4/10/2024 |
SGRY Surgery Partners | $25.83 -2.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 4/10/2024 |
TBRG TruBridge | $8.91 -3.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 4/10/2024 |
THC Tenet Healthcare | $128.47 +0.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 4/10/2024 |
UHS Universal Health Services | $177.70 -0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Underweight -> Underweight | $156.00 | Low | View details for Cantor Fitzgerald rating of Universal Health Services (NYSE:UHS) on 4/10/2024 |
UNH UnitedHealth Group | $524.63 +0.6% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/10/2024 |
AWH Aspira Women's Health | $2.66 +0.8% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/10/2024 |
ACAD ACADIA Pharmaceuticals | $14.79 -0.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $37.00 | Low | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/10/2024 |
AXSM Axsome Therapeutics | $76.54 -1.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/10/2024 |
JAZZ Jazz Pharmaceuticals | $108.99 -1.4% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 4/10/2024 |
LBPH Longboard Pharmaceuticals | $20.69 +0.9% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 4/10/2024 |
MRNS Marinus Pharmaceuticals | $1.33 +2.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $28.00 | Low | View details for Cantor Fitzgerald rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/10/2024 |
NBIX Neurocrine Biosciences | $142.29 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $155.00 | Low | View details for Cantor Fitzgerald rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/10/2024 |
XENE Xenon Pharmaceuticals | $39.80 -1.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 4/10/2024 |
CI The Cigna Group | $338.71 -0.2% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | Analyst S. James | Overweight -> Overweight | $384.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 4/10/2024 |
CVS CVS Health | $57.68 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/10/2024 |
ELV Elevance Health | $547.71 +0.7% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/10/2024 |
HCA HCA Healthcare | $322.86 +0.0% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 4/10/2024 |
Elon’s New Device is About to Shock the World (Ad) Using this device you see above…
Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in…
“The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. |
HCAT Health Catalyst | $6.95 -1.1% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 4/10/2024 |
HUM Humana | $356.20 +0.3% | 4/10/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/10/2024 |
AGIO Agios Pharmaceuticals | $34.34 -1.9% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 4/9/2024 |
VINC Vincerx Pharma | $0.69 -4.2% | 4/9/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/9/2024 |
GPCR Structure Therapeutics | $36.15 +0.8% | 4/9/2024 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight | $65.00 | Low | View details for Cantor Fitzgerald rating of Structure Therapeutics (NASDAQ:GPCR) on 4/9/2024 |
NXPI NXP Semiconductors | $267.72 -0.7% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 4/8/2024 |
KLAC KLA | $747.68 -0.2% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $625.00 -> $800.00 | Low | View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 4/8/2024 |
LRCX Lam Research | $912.07 -3.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $900.00 -> $1,100.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/8/2024 |
MU Micron Technology | $125.29 -2.0% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $135.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 4/8/2024 |
QCOM QUALCOMM | $193.86 +0.3% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 -> $190.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 4/8/2024 |
TXN Texas Instruments | $195.02 +0.0% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 -> $180.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/8/2024 |
WDC Western Digital | $72.10 -2.7% | 4/8/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $70.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 4/8/2024 |
GFS GLOBALFOUNDRIES | $53.95 -0.4% | 4/8/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Neutral | $70.00 -> $55.00 | Low | View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 4/8/2024 |
AMAT Applied Materials | $212.08 -0.9% | 4/8/2024 | Upgraded by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Overweight | $220.00 -> $260.00 | Low | View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 4/8/2024 |
CABA Cabaletta Bio | $12.35 -2.1% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 4/5/2024 |
RARE Ultragenyx Pharmaceutical | $41.87 -1.7% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $107.00 | Low | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 4/5/2024 |
ETNB 89bio | $8.63 -3.8% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $29.00 | Low | View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 4/5/2024 |
MRK Merck & Co., Inc. | $131.19 +0.2% | 4/5/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/5/2024 |
MOH Molina Healthcare | $347.62 +0.8% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $406.00 | Low | View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 4/4/2024 |
UNH UnitedHealth Group | $524.63 +0.6% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $591.00 | Low | View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 4/4/2024 |
SPRO Spero Therapeutics | $1.59 +1.3% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 4/4/2024 |
STOK Stoke Therapeutics | $13.90 -0.9% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Stoke Therapeutics (NASDAQ:STOK) on 4/4/2024 |
ATAI Atai Life Sciences | $1.71 -8.1% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | N/A | View details for Cantor Fitzgerald rating of Atai Life Sciences (NASDAQ:ATAI) on 4/4/2024 |
PRE Prenetics Global | $5.80 -0.9% | 4/4/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $9.00 | Low | View details for Cantor Fitzgerald rating of Prenetics Global (NASDAQ:PRE) on 4/4/2024 |
CNC Centene | $78.06 +1.2% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $90.00 | Low | View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 4/4/2024 |
CVS CVS Health | $57.68 +0.3% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $87.00 | Low | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 4/4/2024 |
ELV Elevance Health | $547.71 +0.7% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $580.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/4/2024 |
HUM Humana | $356.20 +0.3% | 4/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $391.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 4/4/2024 |
TNGX Tango Therapeutics | $7.52 -3.5% | 4/4/2024 | Initiated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Tango Therapeutics (NASDAQ:TNGX) on 4/4/2024 |
INTC Intel | $31.83 -0.6% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $50.00 | Low | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 4/3/2024 |
ANNX Annexon | $4.33 -0.7% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Annexon (NASDAQ:ANNX) on 4/3/2024 |
PRCH Porch Group | $2.79 -0.7% | 4/3/2024 | Target Raised by | Cantor Fitzgerald | Analyst J. Siegler | Overweight -> Overweight | $3.00 -> $5.00 | Low | View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 4/3/2024 |
RIVN Rivian Automotive | $10.50 +3.7% | 4/3/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $23.00 | Low | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 4/3/2024 |
LEGN Legend Biotech | $45.16 -2.6% | 4/3/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $82.00 | Low | View details for Cantor Fitzgerald rating of Legend Biotech (NASDAQ:LEGN) on 4/3/2024 |
AFMD Affimed | $5.25 -3.5% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Affimed (NASDAQ:AFMD) on 4/1/2024 |
CRVS Corvus Pharmaceuticals | $2.29 +4.6% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Corvus Pharmaceuticals (NASDAQ:CRVS) on 4/1/2024 |
VINC Vincerx Pharma | $0.69 -4.2% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight | | Low | View details for Cantor Fitzgerald rating of Vincerx Pharma (NASDAQ:VINC) on 4/1/2024 |
ATNM Actinium Pharmaceuticals | $9.80 -0.5% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $21.00 | N/A | View details for Cantor Fitzgerald rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/1/2024 |
AWH Aspira Women's Health | $2.66 +0.8% | 4/1/2024 | Target Lowered by | Cantor Fitzgerald | - | Neutral -> Neutral | $4.00 -> $3.30 | Low | View details for Cantor Fitzgerald rating of Aspira Women’s Health (NASDAQ:AWH) on 4/1/2024 |
HUMA Humacyte | $6.33 -1.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Humacyte (NASDAQ:HUMA) on 4/1/2024 |
ZVRA Zevra Therapeutics | $4.73 -0.6% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 4/1/2024 |
SCYX SCYNEXIS | $2.77 +14.9% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight | | Low | View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 4/1/2024 |
ASND Ascendis Pharma A/S | $121.12 -1.4% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $173.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 4/1/2024 |
LLY Eli Lilly and Company | $770.00 -0.1% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $815.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/1/2024 |
NVO Novo Nordisk A/S | $131.89 -0.9% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 4/1/2024 |
PFE Pfizer | $28.64 -1.0% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $45.00 | Low | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/1/2024 |
MIGI Mawson Infrastructure Group | $1.05 -3.7% | 4/1/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $1.00 | Low | View details for Cantor Fitzgerald rating of Mawson Infrastructure Group (NASDAQ:MIGI) on 4/1/2024 |
EVLV Evolv Technologies | $2.69 -1.8% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 3/28/2024 |
CMCL Caledonia Mining | $11.09 +3.9% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Speculative Buy -> Hold | | N/A | View details for Cantor Fitzgerald rating of Caledonia Mining (NYSEAMERICAN:CMCL) on 3/28/2024 |
CLSK CleanSpark | $16.03 -2.7% | 3/28/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 -> $20.00 | N/A | View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 3/28/2024 |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
BITF Bitfarms | $1.75 -0.6% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 3/28/2024 |
CIFR Cipher Mining | $3.85 -5.4% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | N/A | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/28/2024 |
IREN Iris Energy | $6.02 +3.3% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $10.00 | N/A | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 3/28/2024 |
RIOT Riot Platforms | $10.06 +0.6% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 3/28/2024 |
WULF TeraWulf | $1.95 -3.5% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | N/A | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/28/2024 |
OUST Ouster | $12.97 +11.2% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $8.00 | N/A | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/28/2024 |
MREO Mereo BioPharma Group | $3.20 -2.1% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | N/A | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/28/2024 |
HRMY Harmony Biosciences | $29.03 -1.0% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 | N/A | View details for Cantor Fitzgerald rating of Harmony Biosciences (NASDAQ:HRMY) on 3/28/2024 |
CXM Sprinklr | $12.51 +0.6% | 3/28/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | N/A | View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 3/28/2024 |
ZS Zscaler | $178.86 -0.3% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Neutral -> Neutral | $230.00 | Low | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 3/27/2024 |
MRK Merck & Co., Inc. | $131.19 +0.2% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $135.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 3/27/2024 |
VNRX VolitionRx | $0.77 -3.8% | 3/27/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $2.50 | Low | View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 3/27/2024 |
SMTI Sanara MedTech | $30.51 -3.8% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $49.00 -> $44.00 | Low | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/27/2024 |
LUCD Lucid Diagnostics | $0.91 +2.3% | 3/27/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.80 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/27/2024 |
LUNR Intuitive Machines | $5.14 -3.2% | 3/22/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $13.00 -> $10.00 | Low | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/22/2024 |
JAZZ Jazz Pharmaceuticals | $108.99 -1.4% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 3/22/2024 |
CLDX Celldex Therapeutics | $38.21 -4.3% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $67.00 | Low | View details for Cantor Fitzgerald rating of Celldex Therapeutics (NASDAQ:CLDX) on 3/22/2024 |
CABA Cabaletta Bio | $12.35 -2.1% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $50.00 | Low | View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 3/22/2024 |
DESP Despegar.com | $14.94 +19.1% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/22/2024 |
MREO Mereo BioPharma Group | $3.20 -2.1% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/22/2024 |
CPRX Catalyst Pharmaceuticals | $16.49 +0.5% | 3/22/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/22/2024 |
SOUN SoundHound AI | $5.05 -1.2% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Underweight | $5.80 -> $4.90 | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 3/20/2024 |
NVO Novo Nordisk A/S | $131.89 -0.9% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 3/20/2024 |
TSHA Taysha Gene Therapies | $3.09 -1.6% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $7.00 | Low | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 3/20/2024 |
WULF TeraWulf | $1.95 -3.5% | 3/20/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $4.00 | Low | View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 3/20/2024 |
JANX Janux Therapeutics | $47.10 -0.9% | 3/20/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $100.00 | Low | View details for Cantor Fitzgerald rating of Janux Therapeutics (NASDAQ:JANX) on 3/20/2024 |
BBIO BridgeBio Pharma | $30.09 -3.1% | 3/19/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 3/19/2024 |
SHLS Shoals Technologies Group | $6.41 -6.3% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $20.69 +0.9% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
GDYN Grid Dynamics | $10.22 -2.5% | 3/13/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $14.00 -> $17.00 | Low | View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 3/13/2024 |
JNJ Johnson & Johnson | $154.64 +0.2% | 3/13/2024 | Reiterated by | Cantor Fitzgerald | Analyst L. Chen | Overweight -> Overweight | $215.00 | Low | View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 3/13/2024 |
CRWD CrowdStrike | $345.93 +2.0% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $400.00 | Low | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/14/2024 |
CPRX Catalyst Pharmaceuticals | $16.49 +0.5% | 3/14/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $34.00 | Low | View details for Cantor Fitzgerald rating of Catalyst Pharmaceuticals (NASDAQ:CPRX) on 3/14/2024 |
MNKD MannKind | $4.59
| 3/15/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $6.50 | Low | View details for Cantor Fitzgerald rating of MannKind (NASDAQ:MNKD) on 3/15/2024 |
DESP Despegar.com | $14.94 +19.1% | 3/15/2024 | Target Raised by | Cantor Fitzgerald | - | Overweight -> Overweight | $11.00 -> $14.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/15/2024 |
SSTI SoundThinking | $14.35 +0.5% | 3/15/2024 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $25.00 | Low | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 3/15/2024 |
MU Micron Technology | $125.29 -2.0% | 3/18/2024 | Target Raised by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/18/2024 |
RNA Avidity Biosciences | $29.50 +2.7% | 3/14/2024 | Initiated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight | $60.00 | Low | View details for Cantor Fitzgerald rating of Avidity Biosciences (NASDAQ:RNA) on 3/14/2024 |
FROG JFrog | $33.10 +0.6% | 3/7/2024 | Target Raised by | Cantor Fitzgerald | - | | $40.00 -> $45.00 | Low | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 3/7/2024 |
EVGO EVgo | $2.28 -3.4% | 3/7/2024 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $5.00 | Low | View details for Cantor Fitzgerald rating of EVgo (NYSE:EVGO) on 3/7/2024 |
ISPO Inspirato | $3.95 -1.0% | 3/7/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $19.00 -> $18.00 | N/A | View details for Cantor Fitzgerald rating of Inspirato (NASDAQ:ISPO) on 3/7/2024 |
DESP Despegar.com | $14.94 +19.1% | 3/7/2024 | Initiated by | Cantor Fitzgerald | - | Overweight | $11.00 | Low | View details for Cantor Fitzgerald rating of Despegar.com (NYSE:DESP) on 3/7/2024 |
CIFR Cipher Mining | $3.85 -5.4% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $5.00 | Low | View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 3/6/2024 |
NPCE NeuroPace | $8.17 -4.6% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst R. Osborn | Overweight -> Overweight | $16.00 -> $18.00 | Low | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/6/2024 |
CERS Cerus | $1.97 +0.5% | 3/6/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $3.00 | Low | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 3/6/2024 |
CRWD CrowdStrike | $345.93 +2.0% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $360.00 -> $400.00 | N/A | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
RIGL Rigel Pharmaceuticals | $0.95 -3.1% | 3/6/2024 | Target Raised by | Cantor Fitzgerald | - | Neutral -> Neutral | $2.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 3/6/2024 |
THC Tenet Healthcare | $128.47 +0.4% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $104.00 | Low | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 3/5/2024 |
ACHC Acadia Healthcare | $66.35 -0.4% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $90.00 | Low | View details for Cantor Fitzgerald rating of Acadia Healthcare (NASDAQ:ACHC) on 3/5/2024 |
HCA HCA Healthcare | $322.86 +0.0% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $335.00 | Low | View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 3/5/2024 |
HCAT Health Catalyst | $6.95 -1.1% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $16.00 | Low | View details for Cantor Fitzgerald rating of Health Catalyst (NASDAQ:HCAT) on 3/5/2024 |
RCM R1 RCM | $12.43 +1.0% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $20.00 | Low | View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 3/5/2024 |
SGRY Surgery Partners | $25.83 -2.3% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $43.00 | Low | View details for Cantor Fitzgerald rating of Surgery Partners (NASDAQ:SGRY) on 3/5/2024 |
TBRG TruBridge | $8.91 -3.7% | 3/5/2024 | Reiterated by | Cantor Fitzgerald | - | Overweight -> Overweight | $24.00 | Low | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/5/2024 |
GTLB GitLab | $56.26 -0.4% | 3/5/2024 | Target Lowered by | Cantor Fitzgerald | - | Overweight -> Overweight | $80.00 -> $70.00 | Low | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 3/5/2024 |
NVDA NVIDIA | $924.79 -2.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $900.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/4/2024 |
NXPI NXP Semiconductors | $267.72 -0.7% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $270.00 | Low | View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 3/4/2024 |
TXN Texas Instruments | $195.02 +0.0% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | - | Neutral -> Neutral | $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 3/4/2024 |
QCOM QUALCOMM | $193.86 +0.3% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $150.00 | Low | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 3/4/2024 |
TER Teradyne | $131.91 +0.3% | 3/4/2024 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Neutral -> Neutral | $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/4/2024 |